BTBehrouz Mansouri Taleghani

Behrouz Mansouri Taleghani

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Behrouz Mansouri Taleghani has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Therapeutic Apheresis

    by Behrouz Mansouri Taleghani, Andreas Buser

    Our last issue of Transfusion Medicine and Hemotherapy with focus on “therapeutic apheresis” has been published 7 years ago, and the editorial started with: “Therapeutic (hem)apheresis (TA) using automated blood processing equipment is a highly developed technique to selectively deplete, exchange, replace, or at least manipulate particular cellular or soluble blood constituents in a broad panel of different diseases. Starting almost 100 years ago by Abel and co-workers in 1914 [1], it still continues to expand as the pathomechanisms of new and old disease entities are elucidated, confirming ‘old’ indications or revealing new rationales for the application of TA” [1]. The phenomenon of an incremental pace of continued rise of knowledge is unquestionably also true for this field of medicine. While, for example, 95 pages were needed for the “2010 ASFA guidelines” [2], the current version of the guidelines had to be extended to 184 pages [3]. This reflects the growing quality and quantity of evidence supporting the use of TA in various diseases and patients, in order to relieve symptoms (symptomatic therapy) or even save lives. The present issue of Transfusion Medicine and Hemotherapy again includes contributions of experts for TA evidenced by their own experience and/or the available literature.


  • Open Access

    Platelet Transfusion Induces Alloimmunization to D and Non-D Rhesus Antigens

    by Johanna Reckhaus, Markus Jutzi, Stefano Fontana, Vera Ulrike Bacher, Marco Vogt, Michael Daskalakis, Behrouz Mansouri Taleghani

    Background: Platelet concentrates (PC) contain residual contaminating red blood cells (RBC), being higher in pooled buffy coat PC (BC-PC) than in apheresis units (AP-PC). Data about PC-induced alloimmunization against non-D Rhesus (Rh) antigens are limited. Methods: For all newly detected RhD and non-D alloantibodies between August 2015 and September /2017 we prospectively evaluated if they were triggered through PC by analyzing for incompatible RBC and/or PC transfusions. Results: We found 5,799 positive results in 89,190 antibody screening tests. We identified 13 newly detectable Rh antibodies through incompatible PCs in 11 patients: 6× anti-D, 4× anti-E, 2× anti-c, 1× anti-f. They received a total of 156 PC (83 BC-PC; 73 AP-PC): 5 patients received incompatible BC-PC only, 1 patient received incompatible AP-PC only, 5 patients received incompatible BC-PC and AP-PC. Quality control showed a mean (range) of 0.304 (0.152-1.662) and 0.014 (0.003-0.080) × 109 RBC/l for BC-PC and AP-PC, respectively. Ten of the 11 patients received RBC transfusions, all of them being antigen-negative for the alloantibodies identified. Conclusions: PC transfusions may not only induce RhD alloimmunization, but also immunization against further Rh antigens such as c, E, and f. The risk seems higher for BC-PC than for AP-PC. The results may have impact on future recommendations of PC transfusion with respect to Rh compatibility and upper limits of RBC contamination.


  • Delayed haemolytic transfusion reaction initially presenting as serum sickness like syndrome

    by Karin Amrein, Pirmin Schmid, Behrouz Mansouri Taleghani

  • Pica, peanuts, and plasma exchange

    by Freidrich Lersch, Stefano Fontana, Felix Nohl, Behrouz Mansouri Taleghani


  • Verbesserung der biochemischen und rheologischen Qualität von Vollblut und Erythrozytenkonzentraten durch Leukozytendepletion vor Lagerung

    by B. Mansouri Taleghani, R. Langer, R. Grossmann, A. Opitz, U. Halbsguth, A. Buchheister, S. Schuler, R. Bachthaler, D. Wiebecke

    Leukozytendepletion - Vollblut - Erythrozytenkonzentrat - Biochemische Lagerungsqualität - Rheologische Lagerungsqualität Leucocyte depletion - Whole blood - Red cell concentrate - Biochemical storage lesion - Rheological storage lesion

    • 1 January 2000
      • Vol. 125  (2) , 111-22

    [Measures for allogeneic blood conservation in surgery].

    by B Mansouri Taleghani, R Grossmann, H B Reith, D Wiebecke, A Thiede

    The aim of all efforts to reduce the need of allogeneic blood transfusions is to avoid associated risks. There should particularly be a favourable effect according to the rate of transfusion-transmitted virus infections and immunological side-effects. The acceptance of an individually adjusted lowest haematocrit level and the minimisation of intra-operative blood loss by the application of optimal surgical techniques are among the most essential strategies to reduce or even avoid allogeneic blood transfusions. In addition the following interventions are generally accepted: Preoperative autologous blood donation, where appropriate supported by erythropoietin Preoperative haemodilution, where appropriate supported by erythropoietin Intra- and postoperative blood salvage Topical or systemic pharmacologic interventions to accelerate haemostasis Controlled hypotension Efficacy and indication of the different measures always depend on the individual circumstances of the specific patient. Therefore one should develop an individual approach for every case. In this context the most important subjects are an optimal coordination and if required an appropriate combination of the discussed methods. Algorithms which preoperatively allow approximate calculation of expected transfusion need may be a meaningful tool to facilitate blood conservation planning. However, at the same time one must consider that all strategies to reduce allogeneic transfusion needs are also associated with particular risks. Therefore one has to weigh carefully the pros and cons prior to their application, including the possible alternative of allogeneic transfusion in one's decision making process.

    • 1 January 1997
      • Vol. 34, 123-7

    [Changes in blood rheology and microcirculation after preparatory combined thrombocytapheresis and plasmapheresis].

    by B Mansouri Taleghani, F Manke, R Langer, H A Henrich, R Grossmann, R Hofmann, D Wiebecke

    Because of anticoagulation, changes in blood composition, and--perhaps--extracorporeal circulation, donor apheresis should cause alterations in hemorheology and hence in the perfusion of the microvasculature. 19 regular blood donors were included. According to our standard protocol for automated collection of blood components with the MCS 3p cell separator, we harvested 1 unit of platelets and 2 units of plasma in each case. Prior to, 1 h after, and 24 h after donation, the following parameters were measured: total serum protein (tsp), hematocrit (hc), whole blood and plasma viscosity (wbv/pv), red cell aggregability (rca) and blood flow velocity of the nail-fold capillaries (bfv). The following parameters decreased 1 h/24 h after donation: tsp (p < 0.001/p = 0.008), elastic wbv (p = 0.018/p < 0.001), viscous wbv (p = 0.85/p = 0.0031), pv (p < 0.001/p < 0.001), static rca (p < 0.001/p = 0.0073), dynamic rca (p < 0.001/p = 0.017). The hc showed an initial increase (p < 0.001) with a subsequent overshooting decrease after 24 h (p < 0.001). 1 h after donation bfv raised (p = 0.0065). It decreased after 24 h and remained only slightly higher than the initial level (p = 0.27). Automated combined collection of platelets and plasma gives rise to: i) Improvement of rheological properties of the donor's blood and increased bfv of his nail-fold capillaries within the 1st h after apheresis. ii) 24 h after donation the improved hemorheological properties remain demonstrable, but the bfv of nail-fold capillaries declines and shows a trend toward the starting-point. iii) Taken together, this is possibly reflecting adapted hemodynamic and vasoconstrictor regulation for altered hemorheological conditions.


    • 1 January 1997
      • Vol. 34, 265-72

    [Therapeutic thrombocytapheresis--effect on hemorheologic parameters].

    by R Langer, D Gross, B Mansouri Taleghani, D Wiebecke, H A Henrich

    Common features of all myeloproliferative diseases (CMPE) are a markedly increased number of platelets and restrictions in the subjective feeling of the patients, comprising symptoms like nausea, headache, sensory deficits and transient paresis. Meanwhile, it has been shown that platelet pheresis (mTD) does not only reduce platelet counts sufficiently but also results in an impressive relief of the subjective complaints. To test the part that rheological mechanisms play hereby, relevant rheological parameters in the blood of 22 CMPE patients and of 8 healthy platelet donors as controls were analyzed before and after treatment with an AS-104 cell separator. Concerning the viscosity of whole blood und the filterability of erythrocytes, there was seen neither a difference between the patients and the controls, nor before and after mTD. As a result of treatment of patients, the moderately raised plasma viscosity was normalized, whereas the aggregation of erythrocytes was significantly lowered. It is concluded that there is an influence of hemorheological conditions on the patient's subjective feeling. These would originate in neurological dysfunctions caused by CMPE-induced restrictions in cortical microcirculation. The erythrocyte aggregation, lowered by mTD, would cause an improvement of microcirculatory fluidity and would, in consequence, abolish the neurological symptoms.

    • 1 January 1996
      • Vol. 33, 141-4

    [Storage-induced rheologic and biochemical changes in erythrocyte concentrates with added solution and possible correlations].

    by B Mansouri Taleghani, R Grossmann, G Waltenberger, W Geise, R Langer, H A Henrich, D Wiebecke

    Rheological integrity is one of the essentials for red blood cells (rbc) in capillary circulation. The influences of metabolical/biochemical changes of rbc on their rheological properties are well known, but (to our knowledge) until now there are no published studies, which cover both quality aspects of packed rbc (prbc) in additive solutions. According to our standard operating procedures (SOP) we prepared prbc in additive solution (SAG-M) and plasma from 16 regular blood donations. The buffy coat was discharged. Following parameters were measured on day 1, 14 and 28: extracellular pH, ATP and 2,3-DPG content of rbc, prbc-viskosity, -filterability, -aggregability and filter clogging rate. For examination of the filterability a 5% rbc-suspension in phoshate buffered solution was prepared, the remaining tests were performed with rbc-samples adjusted to a hematokrit of 40% with fresh frozen autologous plasma. In correlation with the depletion of ATP a decrease of rbc flexibility and changes of shape (for example spherocytosis) are well known from the literature. Our results confirm the assumed time dependent deterioration of rheological patterns of prbc in SAG-M, reflecting in an increase of rbc-viscosity and filter clogging rate and a decrease of rbc-filterability and -aggregability. We also observed the expected decrease of pH, ATP and 2,3-DPG during storage. The influences of biochemical changes on rheological alterations are discussed. Therefore we recommend on demand rheological examinations in addition to metabolical/biochemical analyses for an extended quality assurance program, for instance for testing new additive solutions or major changes of SOP.